X @The Economist
The Economist·2025-11-20 21:40
The surge in new products will enrich pharmaceutical firms in 2026. But competition could also drive down the costs of treatment https://t.co/YupDuYS9Ox ...
The surge in new products will enrich pharmaceutical firms in 2026. But competition could also drive down the costs of treatment https://t.co/YupDuYS9Ox ...